Nabla BioWe use AI to design antibodies for intractable diseases

Nabla Bio: Designing Antibodies with Atomic Precision

Introduction

Nabla Bio is revolutionizing drug design by integrating AI and experimental technologies to create antibodies with atomic precision. Our platform expands the universe of druggable targets, addressing diseases that have eluded effective treatment.

Key Features

• Generative Drug Design: Utilizing advanced AI models to design drugs with unprecedented precision.
• Massively Parallel Experimentation: Combining AI with large-scale empirical measurement to validate drug properties.
• Protein Characterization Technologies: Developing cutting-edge methods to characterize and optimize protein interactions.
• Multiplexed Screens: High-throughput screening to identify the most promising drug candidates.

Use Cases

• Targeting Challenging Disease Targets: Designing antibodies for complex targets such as GPCRs and ion channels.
• Pharmaceutical Partnerships: Collaborating with leading pharmaceutical companies to bring innovative drugs to market.
• Empirical Drug Validation: Ensuring drug safety, efficacy, and manufacturability through rigorous experimental validation.

Pricing

Contact us for detailed pricing information tailored to your specific needs and partnership opportunities.

Teams

Nabla Bio is a focused, creative team based in Cambridge, MA, dedicated to high scientific standards. We are fully in-person, fostering a collaborative and innovative work environment. Interested in joining us? We're hiring!